The authors hypothesize that this upregulation correlates with the heightened levels of various cytokines in PV patients and propose that JAK/STAT proteins could emerge as novel therapeutic targets for PV (226, 227). This evidence concerns the gene SOAT1 and acquired polycythemia vera.